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Identification and Characterization of Endogenous
Langerin Ligands in Murine Extracellular Matrix
Yayoi Tada1, Elisabeth Riedl1,4, Mark S. Lowenthal2, Lance A. Liotta2,5, David M. Briner3, Erika C. Crouch3
and Mark C. Udey1
Langerin is a C-type lectin that is expressed by Langerhans cells (LC) and related immune cells, and believed to
play an important role in antigen recognition and uptake. To determine if Langerin has endogenous ligands, we
generated S protein binding, bacterial recombinant, mouse soluble Langerin, and utilized it as a probe.
Recombinant soluble Langerin did not bind to lymph node or spleen cells, or keratinocytes as assessed via flow
cytometry. However, Langerin did bind to surfaces of primary skin fibroblasts and NIH3T3 cells. ‘‘Ligand
blotting’’ of fibroblast membrane-enriched fractions with Langerin revealed reproducible binding to 140 and
240 kDa proteins resolved in reduced denaturing gels. Characterization of these proteins using mass
spectrometry suggested types I and III procollagen and fibronectin as candidate ligands. Langerin bound
to type I procollagen that was immunoprecipitated from fibroblast lysates, but did not bind to fibronectin
that was immunoprecipitated from fibroblast-conditioned media or mouse plasma fibronectin. These
results indicate that Langerin selectively interacts with at least one ligand in extracellular matrix (type I
procollagen). Langerin may have an unanticipated role in cell–matrix interactions that modulate LC
development, localization, or function.
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INTRODUCTION
Dendritic cells (DC), including epidermal Langerhans cells
(LC), are potent antigen-presenting cells. Subpopulations of
DC are positioned in close proximity to interfaces between
organism and environment where they function as sentinels,
efficiently responding to and capturing foreign antigens in the
peripheral tissues, transporting them to draining lymph
nodes, and presenting antigenic peptides on major histo-
compatibility complex class I or II molecules to naive T cells
(Banchereau and Steinman, 1998). Undoubtedly, DC also
acquire and process self-antigens and present peptides
derived from self-antigens to negative regulatory T cells.
Therefore, DC play critical roles in initiating effector T-cell
immune responses and in maintaining peripheral tolerance. It
has been suggested that ‘‘immature DC’’, including LC, may
preferentially stimulate negative regulatory T cells (Steinman
and Nussenzweig, 2002).
In the periphery, immature DC ingest antigens via fluid-
phase macropinocytosis and using specialized endocytic
receptors including Fc receptors, complement receptors, and
a variety of C-type lectins. C-type lectins bind carbohydrates
in a calcium-dependent manner via highly conserved
carbohydrate recognition domains (CRD) (Figdor et al.,
2002; Geijtenbeek et al., 2004). C-type lectins are grouped
into types I and II, characterized by extracellular N-termini
with multiple CRD or extracellular C-termini with a single
CRD, respectively. Based on distinctive triplets of amino
acids within the CRD, calcium-dependent C-type lectins
can also be subdivided: EPN (Glu-Pro-Asn)-containing
lectins preferentially bind mannose while QPD (Gln-Pro-
Asp)-containing lectins bind galactose (Engering et al., 2002;
McGreal et al., 2004).
LC represent a distinctive DC lineage that preferentially
localize and reside in stratified squamous epithelia, including
skin. LC are known to express several C-type lectins including
DEC-205 (CD205) (Jiang et al., 1995), Dectin-1 (Ariizumi
et al., 2000a), Dectin-2 (Ariizumi et al., 2000b) and Langerin
(CD207) (Valladeau et al., 1999). Langerin is a novel type II
C-type lectin that is expressed primarily by LC and related
cells. Langerin localizes to plasma membranes as well
as Birbeck granules, and induces Birbeck granules formation
in fibroblasts. Birbeck granules are endosomal recycling
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vesicles with a distinctive pentalamellar structure (Valladeau
et al., 2000; Valladeau et al., 2002) that appear to play an
important role in CD1a-restricted antigen presentation
(McDermott et al., 2002; Hunger et al., 2004). Langerin
is comprised of extracellular neck and CRD domains in
addition to transmembrane and intracellular portions. The
neck domain of Langerin mediates trimer formation while the
CRD domain binds preferentially to mannose, N-acetylglu-
cosamine, and fucose (Takahara et al., 2002; Stambach and
Taylor 2003). This sugar specificity is consistent with the EPN
motif in the CRD.
Dermal DC and plasmacytoid DC in human skin also
express several C-type lectins, including DEC-205 (CD205),
DC-SIGN (CD209) and BDCA-2 (Ebner et al., 2004). Among
these, DEC-205 has been shown to be an endocytic receptor
that is involved in antigen processing and presentation (Jiang
et al., 1995). Intensive searches for ligands of C-type lectins
are ongoing in an effort to define the roles that these proteins
play in immune physiology. The most extensively studied
DC C-type lectin is DC-SIGN, a cell surface protein that
is expressed by dermal DC and other DC but not by LC.
DC-SIGN has been shown to bind to ICAM-2 and ICAM-2
(Geijtenbeek et al., 2000a, b), as well as pathogens including
HIV (Geijtenbeek et al., 2000c), Mycobacterium tuberculosis
(Geijtenbeek et al., 2003), Candida albicans (Cambi et al.,
2003), Helicobacter pylori (Bergman et al., 2004), Schisto-
soma mansoni (van Die et al., 2003) and Leishmania
amastigotes (Colmenares et al., 2002). Although Langerin
binds to pathogens such as HIV (Turville et al., 2002),
zymosan and Candida albicans (Takahara et al., 2004),
endogenous ligands have not yet been defined.
In an effort to identify endogenous ligands for Langerin,
we generated soluble (N-terminus truncated) bacterial
recombinant mouse Langerin that retained carbohydrate-
binding activity and used it as probe for cell surface and
matrix Langerin ligands. Our data indicate that mouse
Langerin binds to type I procollagen a(1) produced by
fibroblasts.
RESULTS
Expression, purification, and physical characterization of
recombinant soluble mouse Langerin
The extracellular portion of mouse Langerin, consisting
of neck and CRD domains, was expressed in bacteria as a
tagged fusion protein. As illustrated in Figure 1a, this fusion
protein contains a His tag and a S  TagTM. The S  TagTM is a
15-amino-acid peptide that binds recombinant S-protein with
high affinity (Kd¼ 109 M). The S  TagTM was used to detect
and localize soluble Langerin via horseradish peroxidase
(HRP)-conjugated or FITC-conjugated S-protein. Consistent
with presence of an EPN motif (Figure 1b) that is character-
istic of lectins with mannose specificity, soluble mouse
Langerin bound to mannan-agarose. Langerin was purified
from transformed bacterial lysates using sequential metal
affinity chromatography and mannan-agarose columns as
described in the Materials and Methods section. Essentially
pure 36 kDa soluble Langerin appeared in the fractions eluted
from mannan-agarose column by chelating calcium with
EDTA (Figure 1c; E1, E2). The identity of the protein was
confirmed by blotting with HRP-conjugated S-protein (data
not shown) and anti-mouse Langerin Ab (Figure 1c). The
oligomerization state of soluble Langerin was examined via a
crosslinking assay using NHS-ester (BS3) and fast-perfor-
mance liquid chromatography gel filtration chromatography
(Figure 1d and e). Crosslinking reactions proceeded through a
dimeric intermediate as assessed by SDS-PAGE and blotting
(Figure 1d, lane 2). On gel filtration the major native species
eluted as hexamers (Peak 2: B205 kDa) and trimers (Peak 3:
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Figure 1. Expression, purification, and characterization of soluble recom-
binant mouse Langerin. (a) Schematic diagram of soluble (N-terminus
truncated) Langerin showing the His tag (6X His), S  TagTM, and the
neckþCRD domains. (b) Primary amino-acid sequence of soluble Langerin.
The CRD domain is underlined. The EPN motif characteristic of mannose
selectivity is bolded. (c) Purification of recombinant Langerin. Langerin was
expressed in bacteria and enriched on a Ni2þ column. After refolding in
Ca2þ -containing buffer, soluble fractions (S) were applied to columns of
mannan-agarose and flow-through fractions (FT) were collected. Columns
were washed with Ca2þ -containing buffer and first (W1) and last (W2) wash
fractions were collected. Soluble Langerin that exhibited ligand-binding
activity was eluted in three fractions (E1, E2, and E3) of EDTA-containing
elution buffer. Fractions were analyzed on 4–12% gradient reduced
denaturing gels and stained with Coomassie blue (upper), or transferred to
polyvinylidine difluoride membrane and immunoblotted using anti-Langerin
Ab (lower). (d) Soluble Langerin (predicted 36 kDa monomer) was crosslinked
using various concentrations of the homobifunctional crosslinker BS3 as
indicated and resolved by 10% SDS-PAGE. (e) Soluble Langerin was resolved
by fast-performance liquid chromatography using a Superose 12 size
exclusion column. Experimental molecular masses for these peaks based on
globular standards are: Peak 1, 897 kDa; Peak 2, 205 kDa; and Peak 3,
97 kDa.
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B97 kDa) (Figure 1e). These results strongly suggest that
recombinant Langerin predominates in solution as dimers of
trimeric subunits (hexamers).
Characterization of sugar-binding activity of soluble Langerin
Binding of purified Langerin to mannan-agarose beads was
detected by sequentially incubating soluble Langerin with
beads and FITC-conjugated S-protein (Figure 2a). Binding
was abrogated with EDTA (Figure 2b) or mannan pretreat-
ment (Figure 2c). Solid-phase sugar competition assays were
used to additionally characterize the sugar-binding properties
of soluble Langerin. Monosaccharides were added to active
soluble Langerin and their ability to compete with an
immobilized mannan-rich protein, yeast invertase, for Lan-
gerin binding was assessed in triplicate wells. When sugar
concentrations were low (10 mM), no inhibition was detected
with any of the monosaccharides tested (Figure 2e left). At a
10-fold higher concentration (100 mM), all monosaccharides
except for galactose and lactose showed significant, and
comparable, inhibitory activity (Figure 2b right).
Association of soluble Langerin with cells
To identify endogenous ligands for Langerin, we screened
several types of cells for cell surface Langerin binding
using analytical flow cytometry. Since other DC C-type
lectins, including DC-SIGN and Dectin-1, interact with
T cells (Ariizumi et al., 2000a; Geijtenbeek et al., 2000b),
we first tested Langerin-T-cell binding. Langerin did not bind
to any spleen cells, peripheral lymph node or thymus-derived
cells, regardless of whether cells were activated with
mitogenic anti-T cell (CD3) mAb or not (Figure 3a). We also
assessed Langerin binding to skin-related cells, including
undifferentiated and differentiated mouse primary keratino-
cytes, B16 (mouse melanoma) cells, and fibroblasts.
Although Langerin did not bind to keratinocytes or B16
cells (Figure 3a), it did adhere to cell surfaces of mouse
primary dermal fibroblasts and mouse embryo-originated
NIH3T3 fibroblasts (Figure 3b–e). Langerin–fibroblast binding
was completely inhibited by EDTA, but mannan pretreatment
of Langerin showed minimal inhibition (Figure 3b and c).
Human surfactant protein D (SP-D)-fusion protein did not
bind to fibroblasts (Figure 3d). When cells were treated with
trypsin, Langerin–fibroblast binding was eliminated (Figure
3e). To further characterize this binding, primary fibroblasts
were treated with 0.5 mg/ml of the glycosylation inhibitor
tunicamycin for 72 hours and analyzed for Langerin binding.
Tunicamycin treatment also abrogated Langerin binding
(Figure 3f). Langerin also bound to human primary fibroblasts
(Figure 3b–e) but not to monkey kidney fibroblasts (COS-1
cells) (Figure 3a). These results suggest that Langerin bound to
a cell surface-associated glycoprotein selectively produced
by fibroblasts.
In order to distinguish calcium-dependent Langerin–ligand
interactions and calcium dependent ligand–cell interactions,
additional experiments were carried out. Langerin binding to
NIH3T3 cells was inhibited when Langerin and EGTA were
added to cells. Langerin bound to fibroblasts could also
be eluted with EDTA, indicating that continuous presence
of calcium was necessary for Langerin–fibroblast binding.
Finally, pretreatment of NIH3T3 cells with EDTA did not
elute a Langerin-ligand (data not shown). We next deter-
mined the time course of expression of Langerin ligands on
cultured primary fibroblasts. Fibroblasts were passed using
trypsin, re-plated, and cultured for up to 7 days. As shown in
Figure 4, EDTA-sensitive Langerin binding increased
during the culture, which suggested that Langerin ligands
accumulated on the cell surfaces of fibroblasts throughout the
culture period.
Identification of candidate fibroblast-associated Langerin
ligands
A ligand blot assay using soluble Langerin was subsequently
employed to detect fibroblast-associated Langerin-binding
proteins. Briefly, proteins in whole cell lysates or membrane
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Figure 2. Verification of sugar-binding activity of soluble Langerin. (a–d)
Langerin was incubated with mannan-agarose beads, stained with FITC-
conjugated S-protein and visualized using immunofluorescence microscopy.
Beads were incubated with (a) Langerin, (b) Langerin in EDTA, (c) Langerin
pretreated with mannan, and (d) without Langerin. (e) Sugar-binding
selectivity of Langerin. Ninety six-well plates were coated with 1 mg of yeast
invertase per well and incubated with Langerin (100 mg/ml) alone (column 1),
in the presence of EDTA (column 2), mannan (100 mg/ml) (column 3), and
10 mM (left panel) or 100 mM (right panel) of monosaccharides (columns
4–11). Results shown are representative of two separate experiments.
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fractions of fibroblasts were resolved in reduced, denaturing
SDS gels, transferred to polyvinylidine difluoride membranes,
‘‘blotted’’ with Langerin with or without EDTA or mannan,
and Langerin-binding proteins were detected using HRP-
conjugated S-protein. Bands detected by calcium-reconsti-
tuted, soluble Langerin, but not by Langerin in EDTA,
were considered to be candidate Langerin ligands. Using
whole cell lysates of NIH3T3 cells resolved in 4–12%
gradient gels, a Langerin-binding band with molecular
weight (MW)4185 kDa was detected (Figure 5a and b). In
subsequent experiments, 4% gels were used to improve the
separation efficiency of large proteins.
Crude membrane fractions from primary dermal fibro-
blasts were also subjected to electrophoresis and blotted with
Langerin. Langerin-binding bands with MW of B240 and
B140 kDa were detected in fibroblast membrane prepara-
tions. Langerin binding to the 240 and 140 kDa species was
attenuated when Langerin was added in EDTA or pretreated
with mannan (Figure 5b(1–3)). No bands were detected when
identical samples were blotted with an unrelated C-type
lectin, human SP-D (Figure 5b(4)). In addition, no Langerin-
binding bands appeared in ligand blots carried out with
membrane fractions prepared from tunicamycin-treated
dermal fibroblasts (Figure 5c).
As Langerin bound large MW glycoproteins that asso-
ciated with fibroblasts and accumulated over time in culture,
we reasoned that one or both species might represent
extracellular matrix components. However, Langerin did
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Figure 3. Langerin binds to cell surfaces of skin-derived fibroblasts. Soluble Langerin was incubated with various cells, and cell surface-associated Langerin
was detected using FITC-conjugated S-protein and analytical flow cytometry. (a) Spleen and lymph node cells were stimulated with anti-CD3 Ab for 48 or
72 hours and results obtained with 72 hours stimulated cells are shown. Dashed line: Langerin in EDTA. Solid line: calcium-reconstituted Langerin. (b–e) Skin-
derived fibroblasts were stained with Langerin and human SP-D. (b) Dashed line: Langerin in EDTA. Solid line: calcium-reconstituted Langerin. (c) Effects of
mannan pretreatment on Langerin–fibroblast binding. Dashed line: Langerin in EDTA. Dotted line: calcium-reconstituted Langerin. Solid line: Langerin
pretreated with mannan. (c) Dashed line: human SP-D in EDTA. Solid line: calcium-reconstituted human SP-D. (d) Trypsin sensitivity of fibroblast Langerin
ligands. Cells were treated with 0.025% trypsin for 5 minutes at 371C, washed, and stained with calcium-reconstituted Langerin or human SP-D. Dashed line:
human SP-D. Solid line: Langerin. Results shown are representative of three separate experiments. (f) Tunicamycin-treated (right) and -untreated cells (left) were
stained with Langerin. Dashed line: Langerin in EDTA. Solid line: calcium-reconstituted Langerin. Results shown are representative of three separate
experiments.
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Figure 4. Accumulation of Langerin ligands on fibroblast cell surfaces in
culture. Primary mouse dermal fibroblasts were stained with Langerin at
indicated times and analyzed by flow cytometry. Upper: calcium-reconsti-
tuted Langerin. Lower: Langerin in EDTA. Results shown are representative of
two separate experiments.
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not bind to commercially available basement membrane
matrix (Matrigel) which contained Laminin 1, type IV collagen,
entactin, and heparan sulfate proteoglycans in the ligand blot
assay. Langerin also did not bind to human tenascin-C, or
mouse tenascin-C that was immunoprecipitated from mouse
fibroblast culture supernatants (data not shown).
To establish tentative identities of candidate Langerin
ligands, locations of Langerin-binding bands in ligand blots
were assigned to corresponding Coomassie blue-stained SDS
gels, and target bands identified in Figure 5d as nos. 1 and 2
were analyzed by mass spectrometry (MS). Sometimes the
B240 kDa band appeared as a doublet as shown in Figure
5b, but we focused on the upper band because it was most
reproducible and it appeared to correspond to a band in
Coomassie blue-stained gels. Based on the estimated sizes of
the candidate Langerin ligands and the frequency with which
peptide hits occurred in the target bands, we identified types I
and III procollagen a(1) (140 kDa) and fibronectin (240 kDa)
as possible Langerin ligands. Analysis of band no. 1 revealed
a total of 18 independent peptides derived from fibronectin
precusor protein, whereas 24 peptides derived from type I
collagen a1 precursor (20 peptides) or type III collagen a1
precursor (four peptides) were recovered from band no. 2. No
type I or III collagen peptides were recovered in band no. 1
and no fibronectin peptides were recovered in band no. 2.
A number of other candidate Langerin ligands that were
suggested by the MS results were excluded from immediate
consideration based on molecular characteristics such as
inappropriate size or subcellular localization.
Confirmation of type I procollagen a(1) as a Langerin ligand
To determine if Langerin bound to type I procollagen a(1), we
immunoprecipitated type I procollagen from membrane
fractions of primary fibroblasts solubilized in low concen-
trations (0.2%) of SDS, and assessed Langerin binding.
Commercially available type I collagen that had been
purified from pepsin-digested mouse skin and that did not
contain procollagen was also studied. Type I procollagen was
immunoprecipitated from membrane fractions as shown in
Figure 6a(2). The anti-type I collagen Ab used for immuno-
precipitation bound avidly to type I procollagen and to a1
chains in mature collagen (Figure 6b (2 and 3)). In the ligand
blot assay, Langerin bound to purified type I procollagen
(Figure 6c (left 2)), but not to mature collagen (Figure 6c
(left 3)). Binding to type I procollagen was inhibited when
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Figure 5. Deletion of fibroblast-associated Langerin ligands by ligand
blotting. (a and b) Samples of NIH3T3 whole cell lysates were applied to
4–12% gradient reduced denaturing SDS gels and blotted with Langerin.
(1) calcium-reconstituted Langerin. (2) Langerin in EDTA. The arrow indicates
a band selectively bound by soluble Langerin. Results shown are represen-
tative of two separate experiments. (b) Primary fibroblast membrane-enriched
fractions were applied to 4% Tris-Glycine-reduced denaturing SDS gels and
blotted with (1) calcium-reconstituted Langerin, (2) Langerin pretreated with
mannan, (3) Langerin in EDTA, (4) calcium-reconstituted human SP-D. The
arrows indicate bands selectively bound by Langerin (no. 1B240 kDa, no. 2
B140 kDa). Results shown are representative of five separate experiments.
(c) Proteins in membrane fractions from primary fibroblasts that had been
treated with 0.5 mg/ml tunicamycin for 72 hours, or were not treated, and were
resolved via electrophoresis and then blotted with Langerin. Left lane:
untreated. Right lane: tunicamycin treated. (d) Membrane fractions from
primary fibroblasts were applied to 4% Tris-Glycine-reduced denaturing gels,
stained with Coomassie blue and the indicated bands were subjected to MS
analysis.
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Figure 6. Binding of soluble Langerin to type I procollagen a(1). Proteins
were immunoprecipitated from fibroblast membrane lysates with (1) Rabbit
IgG or (2) anti-type I collagen. (3) Commercially available type I collagen
extracted from skin via pepsin digestion. The arrow indicates a band
corresponding to immunoprecipitated type I procollagen. Samples were
resolved in 4% Tris-Glycine-reduced denaturing gels and (a) stained with
Coomassie blue, (b) immunoblotted with anti-type I collagen or (c) blotted
with calcium-reconstituted Langerin, Langerin pretreated with mannan or
Langerin in EDTA.
www.jidonline.org 1553
Y Tada et al.
Endogenous Langerin Ligands
Langerin was added in EDTA or if calcium-reconstituted
Langerin was pretreated with mannan (Figure 6c (right 2)).
We could not immunoprecipitate type III procollagen from
fibroblast membrane fractions, and thus could not assess
Langerin binding to this extracellular matrix component.
Fibronectin and Langerin binding
We next attempted to examine Langerin binding to fibro-
nectin using the same strategy. Unfortunately, primary
fibroblast membrane-associated fibronectin could not be
immunoprecipitated from mildly denatured membrane frac-
tions because we could not solubilize membrane-associated
fibronectin with mild denaturant (0.2% SDS) (data not shown)
and more denaturing conditions did not allow immuno-
precipitation. We did successfully immunoprecipitate fibro-
nectin from primary fibroblast culture supernatants, but
Langerin did not bind to it (data not shown). Langerin also did
not bind to human or mouse plasma fibronectin, or commer-
cially available human cellular fibronectin (data not shown).
DISCUSSION
We have generated and characterized an N-terminus-
truncated soluble recombinant form of the novel C-type
lectin, Langerin. Since soluble Langerin retained carbo-
hydrate-binding activity, we utilized it to identify endogenous
Langerin ligands produced by skin cells. Characterization of
soluble Langerin via gel filtration chromatography revealed
that the majority of the protein that bound to mannan existed
in solution as hexamers and trimers. This result is compatible
with the results of a previous study that indicated that the
extracellular region of human bacterial recombinant Langerin
exists as a stable trimer in solution (Stambach and Taylor,
2003), and previous results from our laboratory that demon-
strated that multimer formation of soluble recombinant
mouse Langerin requires the neck domain and is necessary
for retention of ligand (mannan)-binding activity (Riedl et al.,
2004). Although we presume that full-length Langerin also
multimerizes on cell surfaces, it is possible that ligand-binding
characteristics of cell surface and soluble Langerin differ.
In addition and in contrast to bacterial recombinant soluble
Langerin, Langerin that is expressed on the surfaces of
eukaryotic cells may be N-glycosylated at several consensus
sites that are located in the neck domain (Valladeau et al.,
2002). It is possible that incorporation of glycosyl residues
outside the CRD could influence ligand binding to some extent.
In the present study, we demonstrated that recombinant
soluble mouse Langerin exhibited higher affinity for mannose
as compared with galactose and lactose; again compatible
results obtained previously in studies of human recombinant
Langerin (Stambach and Taylor, 2003). Recombinant mouse
Langerin bound selectively to mouse and human primary
dermal fibroblasts, a mouse fibroblast cell line (NIH3T3
cells) and several fibroblast-associated glycoproteins in the
presence of calcium. Results of MS analyses suggested
fibronectin as well as types I and III procollagen a(1) as
candidate Langerin ligands.
Although Langerin bound to mouse fibroblast-derived type
I procollagen in ‘‘pull down’’ experiments, it did not bind to
mature type I collagen. This suggests that Langerin interacts
with the C-terminal portion of type I procollagen a(1) that is
cleaved during collagen maturation. This domain contains
asparagine-linked N-acetylglucosamine- and mannose-rich
carbohydrate moieties (Clark and Kefalides, 1978) that, based
on results presented in Figure 6, we predict bind to Langerin
with high affinity. We were not able to purify sufficient
amounts of type III procollagen, which is produced by
fibroblasts in smaller amounts than type I procollagen (Uitto
et al., 1980), and thus could not directly assess Langerin-type
III procollagen interactions. However, based on the sequence
similarities surrounding the N-linked glycosylation sites
(ASQNITYHCKNS) in C-terminal extension peptides of types
I and III procollagen, Langerin binding to type III procollagen
is likely.
MS also identified fibronectin as a candidate Langerin
ligand. We were able to co-localize Langerin-binding sites
and fibronectin in skin sections and Langerin did not bind to
fibroblasts that had been treated with siRNA against
fibronectin (data not shown). However, Langerin also did
not bind to fibronectin that had been immunoprecipitated
from fibroblast-conditioned media or plasma fibronectin. It is
possible that Langerin binds to a fibronectin-associated
protein, rather than to fibronectin itself. Although we
demonstrated that Langerin binds to type I procollagen and
fibronectin type I collagen interactions are expected, we do
not believe that type I procollagen is the only fibroblast-
derived Langerin ligand. First, Langerin type I procollagen
binding was mannan sensitive whereas binding of Langerin
to fibroblasts could not be inhibited by mannan. Second,
Langerin bound to the dermis of adult mouse skin and
apparently colocalized with antifibronectin Ab in the
absence of detectable type I or III procollagen (data not
shown). Thus, although our data suggest that Langerin
binds to fibronectin, or a fibronectin-associated protein other
than type I procollagen, this remains to be conclusively
demonstrated.
The physiologic significance of our findings remains to be
determined. Although most studies of cell surface C-type
lectins have focused on their roles as pattern recognition and
pathogen uptake receptors, Dectin-1 and DC-SIGN have
been implicated in accessory cell–T-cell interactions and DC-
SIGN, LOX-1 and the macrophage mannose receptor may
play a role in leukocyte trafficking by binding to endogenous
ligands (Cambi and Figdor, 2003). Bacteria that infect skin,
including Staphylococcus aureus and Streptococcus pyo-
genes, bind to extracellular matrix components (Vercellotti
et al., 1985; de Bentzmann et al., 2004) and it is possible that
extracellular matrix proteins could form bridges between
bacteria and LC. The collagen-binding lectin Endo180,
a member of the mannose receptor family that is expressed
by fibroblasts, endothelial cells and macrophages (Sheikh
et al., 2000; Wienke et al., 2003) has been implicated in
matrix remodeling that occurs during tissue development and
homeostasis. Although it is possible that Langerin may
facilitate metalloproteinase-dependent matrix degradation
that occurs as LC translocate from epidermis to regional
lymph nodes (Kobayashi et al., 1999), studies of Langerin
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knockout mice do not suggest that Langerin plays an essential
role in LC migration (Kissenpfennig et al., 2005).
Langerin might also be involved in LC localization or in
LC–stromal interactions that influence biologic activities
other than the processes discussed above. LC have been
detected in increased numbers in the dermis in a number of
pathologic conditions in which extracellular matrix compo-
nents accumulate. These pathologic conditions include LC
histiocytosis (Cline, 1994; Geissmann et al., 2001), Dupuyt-
ren’s contractures (Qureshi et al., 2001), hypertrophic scars
(Cracco et al., 1992), and fibrotic reactions surrounding
silicone breast implants (Dolores et al., 2004). Studies
focused on LC/DC–matrix interactions are of particular
current interest because very recent studies suggest that
tissue stromal cells (fibroblasts) are important regulators of
DC differentiation and/or function. Pribila et al. (2004)
recently described a novel lymph node DC subpopulation
that adheres preferentially to type I collagen and fibronectin,
and that is in all likelihood derived from LC. Svensson et al.
(2004) have reported that splenic stromal cells can promote
development of IL-10-producing, tolerance-promoting mouse
DC from lineage-negative bone marrow progenitors without
exogenous cytokines. In addition, Zhang et al. (2004) have
reported that splenic stromal cells initiated proliferation of
mature DC in a fibronectin-dependent manner. Acquisition of
negative regulatory activity by these DC required both DC-
stromal cell contact and stromal cell-derived tumor growth
factor-b1. Immediate precursors of LC have not been well
characterized, but tumor growth factor-b1 is known to be
required and both long lived, slowly cycling dermal cells and
peripheral blood cells can contribute to LC repopulation. We
speculate that LC development from dermal precursors is
influenced by stromal cells and extracellular matrix, and that
Langerin may be involved in these facilitating interactions.
However, the apparent normalcy of LC number and function
of LC in Langerin knockout mice (Kissenpfennig et al., 2005)
argues against an absolute requirement for Langerin in LC
development or localization. Definitive data awaits isolation
and characterization of the dermal precursors and elucidation
of their growth and differentiation requirements.
MATERIALS AND METHODS
Mice
Newborn BALB/c mice and 6- to 8-week-old C57BL/6 mice were
purchased from the National Cancer Institute Animal Production
Program and housed and used in accordance with institutional
guidelines.
Reagents and antibodies
Extracellular matrix components included: mouse type I collagen
(Chondrex Inc., Redmond, WA), mouse plasma fibronectin (Mole-
cular Innovations, Southfield, MI), human plasma fibronectin
(Invitrogen, Carlsbad, CA), human cellular fibronectin (Sigma-
Aldrich, St Louis, MO), human tenascin-C (Chemicon International
Inc., Ternecula, CA), and BD Matrigel (BD Pharmingen, San Diego,
CA). For mouse fibronectin, tenascin-C, and types I, III, and IV
collagen staining, blotting and immunoprecipitation, the following
Ab were used: rabbit anti-mouse fibronectin (Biogenesis, Kingston,
NH), rat anti-mouse tenascin C mAb and rabbit anti-mouse types I,
III, and IV collagen (Abcam Inc., Cambridge, MA), rabbit IgG (Santa
Cruz Biotech, Santa Cruz, CA), and HRP-conjugated goat anti-rabbit
IgG Ab (Santa Cruz Biotech).
Langerin was blotted with chicken anti-mouse Langerin Ab raised
against a 10-amino-acid peptide corresponding to a sequence
located near the C-terminus of mouse Langerin (Riedl et al., 2004)
or with control, non-immune chicken Ig (Aves Labs Inc., Tigard, OR)
and HRP-conjugated goat anti-chicken IgY (Kirkegaard & Perry
Laboratories, Gaithersburg, MD). Chemicals used for MS are as
follows: acetonitrile (HPLC grade), ammonium bicarbonate
(NH4HCO3), iodoacetamide (97%), methanol (99þ%), and dithio-
threitol all purchased from Sigma-Aldrich; trifluoroacetic acid
(sequanal grade) from Pierce Biotechnology (Rockford, IL); formic
acid (88%), and acetic acid (glacial) from Mallinckrodt Baker
(Phillipsburg, NJ). H2O was doubly distilled in house with a Kontes
High Purity Water System. Porcine sequencing grade modified
trypsin was purchased from Promega (Madison, WI).
Cells and cell lines
NIH3T3 fibroblasts and COS-1 cells were purchased from the
American Tissue Type Collection (ATCC, Manassas, VA). B16
melanoma cells were provided by Dr James Yang (NCI). Primary
keratinocytes and dermal fibroblasts were propagated from neonatal
BALB/c mouse skin as previously described (Weinberg et al., 1993).
Normal human primary foreskin fibroblasts were isolated and
cultured in an analogous fashion. Keratinocytes propagated in low
calcium-containing media are designated undifferentiated keratino-
cytes. In some experiments, keratinocytes were additionally cultured
in 1.3 mM calcium-containing medium. Spleen, thymus, and peri-
pheral lymph node (cervical, popliteal, and inguinal) cell suspensions
were prepared after mechanical disruption of the corresponding
tissues. Primary fibroblasts, NIH3T3 fibroblasts, COS-1 cells, and B16
melanoma cells were cultured in DMEM containing 10% fetal bovine
serum, glutamine and penicillin/streptomycin. Spleen and lymph
node cells were cultured in RPMI-1640 containing 10% fetal bovine
serum, 5 105 M b-mercaptoethanol (Sigma-Aldrich), glutamine and
penicillin/streptomycin.
Expression and purification of soluble mouse Langerin and
human SP-D-fusion proteins
Soluble mouse Langerin was expressed and purified as previously
described with slight modification (Riedl et al., 2004). Briefly, the
region of the cDNA encoding the extracellular domains of Langerin
was inserted into pET-30a(þ ) vector (Novagen, San Diego, CA), and
sequence verified. The plasmids were subsequently used to trans-
form E. coli RosettaBlue competent cells (Novagen). Bacteria
cultured overnight in Luria-Bertani medium containing 30 mg/ml
kanamycin were collected and lysed in 6 M guanidine-HCl, 20 mM
Tris-HCl (pH 8.0), 500 mM NaCl buffer and purified using Ni2þ -
nitrilotriacetic acid resin (Novagen). After extensive dialysis against
25 mM Tris-HCl (pH 8.0), 150 mM NaCl, 25 mM CaCl2 (loading
buffer) with 15% glycerol, insoluble precipitate was removed by
centrifugation at 100,000 g for 1 hour at 41C. The supernatant was
loaded onto a 5 ml mannan-agarose column (Sigma-Aldrich) that
had been pre-equilibrated with loading buffer. The column was
washed with 25 ml loading buffer and eluted with 2 6 ml fractions
of elution buffer (25 mM Tris-HCl (pH 8.0), 150 mM NaCl, 10 mM
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EDTA). As indicated, the binding activity of purified Langerin
was restored by adding CaCl2 to final concentration of 40 mM, and
incubating for 5 minutes at 41C. Only affinity-purified soluble
Langerin was utilized in the studies described herein. To generate
a control protein corresponding to the neck þ CRD domains of
another mannose binding C-type lectin, human SP-D, was cloned
into pET-30a(þ ) vector (Crouch et al., 2005). Human soluble
SP-D protein was generated and purified using the procedure
described for Langerin.
Crosslinking assays and gel filtration chromatography
Soluble Langerin was dialyzed into 50 mM HEPES, 500 mM NaCl (pH
7.5). Of this material, 3mg was crosslinked using the homobi-
functional crosslinker bis(sulfosuccinimidyl)suberate (BS3; Pierce
Biotechnology) at various concentrations (0.01–0.5 mM). After
quenching with Tris-HCl, Langerin species were resolved by SDS-
PAGE under reducing conditions, and detected using horse radish
peroxidase-conjugated S-protein (Novagen, San Diego, CA). To
further characterize the quaternary structure of soluble Langerin,
50 mg of recombinant protein was subjected to fast-performance
liquid chromatography in 50 mM Tris-HCl (pH 7.5), 500 mM NaCl
using a Superose 12 size exclusion column (Amersham Biosciences,
Buckinghamshire, UK). Experimental molecular masses were deter-
mined by plotting elution position versus logMW using globular
protein standards (Bio-Rad Laboratories, Hercules, CA).
Sugar competition assays. Ninety six-well microplates (Polysorb;
Nalge Nunc International, Rochester, NY) were coated with 1 mg/
well of yeast invertase (Sigma-Aldrich) in phosphate-buffered saline
(PBS) overnight at 41C. After washing with wash buffer (50 mM Tris-
HCl (pH 7.5), 150 mM NaCl, 0.05% Tween-20), wells were blocked
with 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% gelatin by
incubating for 1 hour at 371C. After additional washing, 20 mg of
Langerin was added to each well in 200 ml of elution buffer
containing 3% fetal bovine serum. For sugar inhibition experiments,
Langerin was first reconstituted with calcium and then sugars
(Sigma-Aldrich) were added to final concentrations of 10 or 100 mM,
or a final concentration of 100 mg/ml in the case of mannan. After
incubating for 1 hour at 41C and washing, 200 ml of HRP-conjugated
S-protein (1:5000 dilution; Novagen) was added to each well in
blocking buffer and incubated 1 hour at 41C. After washing,
3,30,5,50-tetramethyl benzidine substrate solution (Pierce Biotech-
nology) was added (100 ml/well). Enzyme reactions were stopped
with 2N H2SO4 at appropriate time points and optical densities at
450 nm were determined.
Flow cytometry
To detect Langerin binding to cell surfaces, cells were suspended in
PBS supplemented with 3% fetal bovine serum and 0.1% NaN3
(FACS buffer) and incubated with 10 mg/ml of Langerin or human
SP-D-fusion proteins reconstituted with calcium, Langerin or human
SP-D in EDTA, or Langerin pretreated with 100 mg/ml mannan
(Sigma-Aldrich) for 30 minutes at 41C, washed twice, and then
incubated with FITC-conjugated S-protein for 30 minutes at 41C. In
selected experiments, after Langerin binding, cells were incubated in
2.5 mM EDTA or EGTA in PBS or PBS alone for 5 minutes at 41C,
washed in the same buffer, and then additional two washes were
carried out in FACS buffer. Spleen and lymph node T cells were
activated by culturing them on anti-mouse CD3mAb- or Hamster
IgG mAb (BD PharMingen, San Diego, CA)-coated microtiter plates
for 48 or 72 hours (Nakajima et al., 2002). Cells grown in tissue
culture were detached from culture dishes by incubation in 1 mM
EDTA in the absence of proteases. In some experiments, fibroblasts
were treated with 0.025% trypsin in PBS for 5 minutes at 371C just
before staining, or were treated with 0.5 mg/ml tunicamycin (Sigma-
Aldrich)-containing medium for 72 hours at 371C prior to staining.
Cell viability was always 495% as assessed by trypan blue
exclusion. Control cultures for tunicamycin-treated cells were
exposed to an equal volume of tunicamycin diluent (10 mM NaOH),
the final concentration of which was determined not to affect the pH
of the culture medium. Samples were analyzed using a FACScan
flow cytometer equipped with CellQuest software (BD Biosciences,
Mountain View, CA). Propidium iodide-permeable (nonviable) cells
were excluded from analyses.
Confocal laser microscopy
Mannan-agarose beads were incubated with Langerin in FACS buffer
for 30 minutes at 41C, and then with FITC-conjugated S-protein for
30 minutes after washing twice in FACS buffer. Stained beads
were analyzed using a personal confocal laser microscope (Nikon,
Tokyo, Japan).
Immunoblotting
Samples were dissolved in NuPAGE LDS Sample Buffer or Tris-
Glycine SDS Sample buffer with NuPAGE Sample Reducing Agent
(Invitrogen) and denatured by heating 5 minutes at 951C. SDS-PAGE
was performed with NuPAGE 4–12% Bis-Tris gels and MES
running buffer, or 4% Tris-Glycine gels and TrisGly running buffer
(Invitrogen), and protein was routinely visualized with Gel Code
Blue Stain reagent (Pierce Biotechnology). Resolved proteins were
transferred to Immobilon-P membranes (Millipore, Bedford, MA),
and were blotted using the indicated Ab and visualized using
SuperSignal Chemoluminiscent Substrate (Pierce Biotechnology) in
conjunction HRP-detecting Ab.
Ligand blot assay using soluble recombinant Langerin-fusion
protein
Crude membrane fractions of primary fibroblasts were prepared by
differential extraction. Cells were lysed and cytoplasmic and nuclear
proteins were extracted using M-PER mammalian protein extraction
reagent (Pierce Biotechnology) according to the manufacturer’s
instructions leaving a residual insoluble membrane-enriched frac-
tion. Whole cell lysates of NIH3T3 cells, crude membrane fractions
of primary fibroblasts and extracellular matrix components were
dissolved in reducing SDS sample buffer, subjected to SDS-PAGE
and transferred to membranes as described above. Membranes were
sequentially blotted with Langerin or human SP-D-fusion proteins
(each at 5mg/ml) reconstituted with calcium or in EDTA and HRP-
conjugated S-protein, and then developed. To co-localize bands in
SDS gels and on membranes prior to MS analysis, transferred
membranes were stained for protein using Memcode Reversible
Protein Stain kit for polyvinylidine difluoride (Pierce Biotechnology)
according to the manufacturer’s instructions, and the positions
of visible bands were marked with a pen. These marks corresponded
to white spots on developed films, allowing locations of Langerin-
binding proteins in SDS gels to be precisely determined.
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MS analysis
One-dimensional gel separation and digestion: Replicate samples
were run in one-dimensional gels, and bands with identical
MWs were excised and pooled in a microcentrifuge tube. Bands
were washed 3 with ddH2O and de-stained with 25 mM
NH4HCO3 in 50% acetonitrile prior to complete dehydration
in a Hetovac Rotofor lyophilizer. Dehydrated gel bands were
reduced and alkylated with 10 mM dithiothreitol and 55 mM
iodoacetamide, incubated at 41C for 1 hour in porcine-modified
trypsin (20 mg/ml, Promega) and allowed to digest overnight
at 371C in 25 mM NH4HCO3. Supernatants were recovered and
peptides were extracted in three iterations with 70% acetonitrile/5%
formic acid.
MuLiquid chromatography/MS/MS analysis. Pooled peptide
samples were lyophilized to near dryness and reconstituted in 6.5 ml
of high-performance liquid chromatography buffer A (95% H2O/5%
acetonitrile/0.1% formic acid) for mass spectral analysis. Micro-
capillary reverse phase liquid chromatography/MS/MS analysis
was performed with Dionex’s LC Packings liquid chromatography
system coupled online to a ThermoFinnigan LCQ Classic ion
trap mass spectrometer (San Jose, CA) with a modified nanospray
source. Reverse phase separations were performed using an
in-house, slurry packed capillary column. The column is a 75 mm
i.d., 360 mm o.d., 10 cm long fused-silica packed capillary of C18
silica-bonded, 5 mm beads with 300 Angstrom pore-sized material
(Vydac, Hesperia, CA). A m-pre-column PepMap C18 cartridge
(Dionex) acted as a desalting column. Sample was injected in ml
pick-up mode and washed with HPLC buffer A for 5 minutes
prior to a linear gradient elution with HPLC buffer B (95%
acetonitrile/5% H2O/0.1% formic acid up to 85% over 95 minutes)
at a flow rate of 200 nl/minute. Full MS scans were followed by four
MS/MS scans of the most abundant peptide ions (in a data-dependent
mode) and collision-induced dissociation was performed at a
collision energy of 38%.
Data analysis. Data analysis was performed by comparing MS/MS
spectra against the European Bioinformatics Institute of the non-
redundant proteome set of Swiss-Prot, TrEMBL and Ensembl entries
through the Sequest Bioworks Browser (ThermoFinnigan). Peptides
were considered legitimate hits after filtering the correlation scores
(Table 1) and manual inspection of the MS/MS data. The criteria used
to filter data in this manuscript are at least as stringent as those
reported in most literature citations.
Accepted peptide hits were required to have an Xcorr ranking¼ 1
relative to all other peptides in the database. Proteins identified by
single peptide sequences were discriminated with a more rigorous
Xcorr scoring filter of the Sequest output.
Immunoprecipitation of type I procollagen, tenascin-C, and
fibronectin
Crude membrane fractions of primary mouse fibroblasts were
prepared as described above. After solubilization in 0.2% SDS and
heating for 5 minutes at 951C, PBS was added to decrease the final
concentration of SDS to 0.1%. Anti-type I collagen Ab was added
and incubated overnight at 41C. Immune complexes were captured
and isolated using a Seize Classic (A) immunoprecipitation kit
(Pierce Biotechnology). Tenascin-C and fibronectin were immuno-
precipitatied from 5x concentrated (Microcon YM-100; Millipore
Corporation, Bedford, MA) culture supernatants of primary fibro-
blasts using the Ab listed above and the same kit.
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